title: Pompholyx after IV immunoglobulin therapy for neurologic disease.
authors.forename: K
authors.initials: K
authors.lastname: Ikeda
authors.forename: Y
authors.initials: Y
authors.lastname: Iwasaki
authors.forename: Y
authors.initials: Y
authors.lastname: Ichikawa
authors.forename: M
authors.initials: M
authors.lastname: Kinoshita
mesh_terms: D000368:Aged; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D011146:Eczema, Dyshidrotic / Q000209:etiology*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000097:blood; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000628:therapy*; D012008:Recurrence
chemical_list: D007074:Immunoglobulin G